BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 13, 2003
View Archived Issues
Promising findings announced for plague vaccine
Read More
Posttraumatic AMPA receptor antagonism results in neuroprotection in a rat head injury model
Read More
Structural changes in prostate DNA as a potential approach for predicting prostate cancer
Read More
Efficacy of a new diphenylchlorin sensitizer for PDT
Read More
Topical ciclosporin conjugate reported safe and effective in psoriasis
Read More
Topical 5-FU combined with celecoxib reduces UVB-induced skin tumors in mice
Read More
Spanish researchers synthesize novel synthetic glycoside with potent antitumor activity
Read More
FDA approves new flexible dosing regimen for Lantus
Read More
Guilford enters NAALADase licensing agreement with Pfizer
Read More
Adderall XR program in adolescents to extend marketing exclusivity
Read More
Progen updates development status of PI-88, PI-166
Read More
Licensing, INDs and acquisition at Inflazyme during the last quarter
Read More
Novel agents with utility in immune disorders identified at Kyorin
Read More
Kureha patent describes new CXCR4 antagonists for HIV infection, rheumatism and cancer
Read More
Nicotinic alpha7 agonists/partial agonists and their use covered by Mitsubishi patent
Read More
New MMP, TACE and/or aggrecanase inhibitors prepared by BMS researchers
Read More
New HER2 kinase inhibitors prepared and tested at Takeda
Read More
Lilly scientists identify phenanthrene-based LXR activators
Read More
5-HT1A antagonists with utility in urinary tract disorders under study at Recordati
Read More
Novel potassium channel activators discovered at Takeda
Read More
Synercid launched in Japan
Read More
BioTie enters VAP-1 licensing agreement with Seikagaku
Read More
ConjuChem initiates U.S. trial for DAC:GLP-1
Read More
Ligand, Lilly extend diabetes and cardiovascular drug discovery collaboration
Read More
Novartis acquires Enablex
Read More
Novartis acquires 51% of Idenix capital stock
Read More
Elidel approved in Canada for eczema
Read More
Antitumor and antimetastatic effects of a vitamin E analogue
Read More
Fab fragment targeting alpha5beta1 integrin inhibits CNV in monkeys
Read More